Press Release

United States Healthcare Advertising Market to Grow at a CAGR of 4% During 2024-2032, Aided by the Increasing Healthcare Spending

United States Healthcare Advertising Market

According to a new report by EMR titled, ‘United States Healthcare Advertising Market Report and Forecast 2024-2032’, the market reached almost USD 22.84 billion in 2023. The market is further expected to grow at a CAGR of 4.00% between 2024 and 2032 to reach a value of almost USD 29.11 billion by 2032.

The United States healthcare advertising market is expected to be aided by the rising spending in the healthcare and pharmaceutical sectors. In 2022, United States healthcare spending reached USD 4.5 trillion, growing 4.1% from the previous year. This amounted to USD 13,493 per person. Healthcare spending accounted for 17.3% of the nation's Gross Domestic Product in the same year.


Healthcare Contribution in USA GDP 2022


Significant investment in advertising across various sectors is shaping the market dynamics of the US healthcare advertising market. In June 2023, MullenLowe Group secured a contract with the Department of Health and Social Care (DHSC) after a competitive pitch managed by the Crown Commercial Service. Their brief includes creating campaigns addressing cardiovascular diseases and supporting the Swap to Stop Smoking scheme. Building on past collaborations, MullenLowe will focus on mental health, early childhood development, and driving innovation in DHSC's communications, aiming to engage diverse audiences effectively.


Read more about this report REQUEST FREE SAMPLE COPY IN PDF


Market Breakup by Product Type:

  • The market is segmented based on product type into pharmaceuticals (small molecule drugs), advertising market, biopharmaceuticals market, vaccines market, and over-the-counter drugs market, among others.


Key Findings of the Report:

  • The growth of the healthcare and pharmaceutical sectors supports substantial advertising investments for innovative medical products and solutions.
  • Significant investment in advertising is reshaping the dynamics of the US healthcare advertising market, with government initiatives to bring about awareness about several diseases including cardiovascular disease, TB, HIV, STDs, and diabetes, among others.
  • The emphasis on addressing healthcare challenges, such as shortages of medical professionals and public health concerns like smoking cessation, drives the need for targeted advertising campaigns.


Key Offerings of the Report:

  • The EMR report gives an overview of the United States healthcare advertising market for the periods (2018-2023) and (2024-2032).
  • The report also offers historical (2018-2023) and forecast (2024-2032) market information for the product type and major regions of healthcare advertising.
  • The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.


The major players in the United States healthcare advertising market are Johnson & Johnson, Inc, Pfizer Inc, Merck & Co., Inc, GlaxoSmithKline plc., Eli Lilly and Company, Novartis AG, Sanofi-Aventis U.S. LLC, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, and Bristol- Myers Squibb Company, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.


Key Highlights of the Report

Base Year 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
Breakup by Product Type
  • Pharmaceuticals (Small Molecule Drugs) Advertising Market
  • Biopharmaceuticals Market
  • Vaccines Market
  • Over-the-Counter Drugs Market
  • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Johnson & Johnson, Inc 
  • Pfizer Inc
  • Merck & Co., Inc
  • GlaxoSmithKline plc.
  • Eli Lilly and Company
  • Novartis AG
  • Sanofi-Aventis U.S. LLC
  • AstraZeneca
  • F. Hoffmann-La Roche Ltd
  • Bayer AG
  • Bristol- Myers Squibb Company
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.


About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.


EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.


Contact Us:

Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790


*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.